• 한국임상수의학회지
• /
• 제40권3호
• /
• pp.175-181
• /
• 2023

Fucoidan extracted from brown seaweed has a variety of biological activities. Neutrophil extracellular traps (NETs) formation is an immune response for the invasion of pathogens. Neutrophils release granule protein and chromatin that form extracellular fibers that bind microbes. These NETs degrade virulence factors and kill bacteria. The aim of this study was to investigate the effect of fucoidan on NET formation of porcine peripheral blood polymorphonuclear cells (PMNs). The NET formation was determined by fluorescence emission of propidium iodide (PI) in PMNs by a fluorescence microplate reader. The production of tumor necrosis factor (TNF)-α from peripheral blood mononuclear cells (PBMCs) was measured by ELISA method. Fucoidan itself did not show any direct effect on NET formation. However, NET formation of PMNs was increased by the culture supernatant from PBMCs treated with fucoidan. The NET formation of PMNs were also enhanced by treatment with recombinant porcine (rp) TNF-α. The ability of culture supernatant from PBMCs treated with fucoidan to increase the NET formation of PMNs was inhibited by addition of goat anti-rp TNF-α polyclonal antibody (pAb) (IgG) prior to the culture. The increase of NET formation by rp TNF-α was also inhibited by goat anti-rp TNF-α pAb (IgG). The level of TNF-α in culture supernatant from PBMCs was increased by treatment with fucoidan. These results suggest that fucoidan increases porcine NET formation, which is mediated by TNF-α produced from PBMCs.

• 한국식품영양과학회지
• /
• 제24권6호
• /
• pp.837-842
• /
• 1995

고추가루 첨가 식이가 체액성 면역기능에 미치는 영향을 조사하였다. 실험동무로 흰쥐를 사용하여 대조군과 2%, 5%, 10% 고추가루 첨가 식이군을 설정한 후 27일간 실험식이로 사육하였다. 실험종료 10일 전에 각군의 흰쥐를 면양적혈구로 세차례 면역시킨 후 항체생성 세포수 및 혈청 중 항체 농도 등 체액성 면역기능을 중심으로 조사하였다. 그 결과, 대조군에 비해 고추가루 첨가 식이군의 항체 생성 세포수, 적혈구 응집반응 및 혈청중 항체 농도가 높은 것으로 나타났으며, 또한 이때 고추가루 첨가식이군의 각 장기조직 중 AsA 함량은 대조군에 비해 높은 것으로 나타났다. 이들 결과로 보아, 고추성분은 체액성 면역기능의 활성화에 기여하는 물질을 함유하고 있을 뿐만이 아니라, AsA의 공급효과가 뛰어난 것이 확인되었다.

• Toxicological Research
• /
• 제16권4호
• /
• pp.269-274
• /
• 2000

Epoxidised soya bean oil (ESBO, 1000, 2000 or 4000 mg/kg) was orally administered to BALB/c mice daily for 28 consecutive days, and the control mice were exposed to vehicle (corn oil). Mice were immunized and challenged with sheep red blood cells (SRBC) or bovine serum albumin (BSA). In groups exposed to ESBO, the body weight gains and the relative lymphoid organ weights were not significantly changed as compared with control group. Secondary IgG antibody response to BSA was not significantly changed by ESBO, but plaque-forming cell (PFC) response to SRBC was significantly suppressed in mice treated with 4000 mg ESBO/kg/day. The mitogenic response of splenic B cells induced by LPS was not effected by ESBO in any of the groups. These results indicate that ESBO did not induce significant humoral immune response at a dose less than 2000 mg/kg/day in mice.

• Journal of Animal Science and Technology
• /
• 제46권3호
• /
• pp.495-502
• /
• 2004

장출혈성대장균 O157:H7의 eae유전자 산물인 intimin은 장 상피세포의 부착성을 조절하는 단백질로 알려져 있다. Intimin의 C-말단 아미노산 잔기와(His)$_6$이 혼합되어 이루어진 plasmid를 작성하여 재조합 단백질(34kDa)을 발현시켰다. 발현된 재조합 intimin 단백질의 면역원성을 확인하기 위해 토끼와 산란계에서 항혈청 및 난황항체(IgY)를 제조하였다. O157:H7에서 분리한 세포외막단백질(OMPs)과 제조된 항혈청과의 western blot상의 반응에서 약 94kDa의 위치에서 양성반응을 보여 발현된 재조합 단백질의 면역원성 효과가 확인되었다. 면역원성이 확인된 단백질을 산란계에 면역한 결과, 면역 후 4${\sim}$6주 경부터 높은 수준의 항체가 형성되었다. 재조합 intimin 단백질에 대한 난황 항체의 항원결합능력 조사를 위하여 중화반응시험을 수행한 결과, 재조합 intimin 단백질에 대한 난황 항체가 O157:H7과 강하게 결합하는 것으로 나타났다. 따라서 본 연구에서 발현된 재조합 intimin 단백질은 토끼와 산란계의 면역반응을 유도할 수 있는 효율적인 면역원임과 동시에 난황 항체 생산을 위한 항원으로의 이용가능성이 확인되었다.

• Parasites, Hosts and Diseases
• /
• 제36권1호
• /
• pp.37-46
• /
• 1998

인체 간흡충증의 현증감염 시기에 생산된 특이 IgG 항체와 반응하는 간촘충 특이항원을 규명하였다. 간흡충 성충의 조항원 및 서로 다른 조건에서 회수한 4가지 분비배설항원 (CsE)의 항원성을 면역이적법 소견으로 비교하였다 CsE2의 30. 7 kDa 항원이 간흡충 환자혈청과 강한 면역반응을 보였다. 이 항원들은 프라지콴텔 완치 후 6개월 혈청과는 반응하지 않았으나 투약 후 간흡충 충란이 검출된 환자의 치료 후 혈청과는 반응하여 현증감염의 면역반응과 관련된다고 판단하였다. 그러나. 30 Ka항원은 폐흡충 요코가와흉충 감염혈청과 교차반응하였고. 7 kDa 항원은 반응하지 않았다. 또. 30 kDa 항원은 일부 간흡충 과거 감염자 혈청과 반응하였으나 7 kDa 항원은 반응하지 않아 7 님)a 항원의 특이도가 높았다 간흡충 유행지역에서 7 kDa 항원의 민감도를 파악한 바 간흡충 현증감염자 25명 중 23명 (92%) 간홉충 요코가와흡충 중복감염자 11명 중 10명 (91%)과 반응하였다. 반면 간흡충 과거감염자 15명 중 6명 (40%), 요코가와흡충 감염자 7명 중 3명 (43%)과 반응하였다. 따라서. CsE2의 7 kDa 항원은 인체 간흡충 현증감염의 표식자가 되는 간흡충 특이 항원으로 판단된다.

• Archives of Pharmacal Research
• /
• 제20권5호
• /
• pp.396-403
• /
• 1997

In order to direct the form of the immune response in an antigen-specific manner, we constructed a fusion protein (OVA/IL12) that contained the T cell-dependent antigen, ovalbumin (OVA), covalently linked to murine interleukin-12 (IL-12). The OVA/IL12 protein was produced in a baculovirus expression system and was purified by anti-OVA immunoaffinity chromatography. The purified OVA/ILI2 protein displayed potent IL-12 bioactivity in an IL-12 proliferation assay. BALB/c mice immunized with the OVA/IL12 protein produced increased quantities of anti-OVA IgG2a antibody compared with mice immunized with recombinant OVA alone. Lymph node cells from the immunized mice with the OVA/IL12 protein produced large amounts of IFN-,Y when restimulated in vitro with OVA, while those from mice immunized with the OVA protein produced little or no IFN-.gamma.. In contrast, immunization with a mixture of OVA and free recombinant IL-12 also induced IFN-.gamma. production, which was not OVA-specific. These studies indicate that the OVA/IL12 fusion protein can induce OVA-specific, Th1-dominated immune responses, and that the covalent linkage of OVA and IL-12 confines the effect of IL-12 to OVA-specific cells.

• KSBB Journal
• /
• 제7권4호
• /
• pp.290-295
• /
• 1992

여러 가지 생리랴 활성기능을 가지고 있다고 알려진 유산균에 대해 활성산소 소거효과 및 면역 증강 효과 를 검토하여 보았다. 유산균 배양액 및 파쇄액의 활성산소 소거효과를 각각 다른 검색방법에 의해 살펴 본 결과, 유산균 배 양액 및 Mn-complex는 XOD assay와 paraquat에 대한 반응에서 활성 산소 소거 효과가 뛰어나 superoxide anion radical 소거와 관련이 있는 것으로 나타났고, 배양액 중에서 $Mn^{2+}$와 결합하는 성분은 누로 peptide나 amino acid인 것으로 추정된다. 한편 cell free extract는 광용혈 시험에서 좋은 효과를 나타내어 singlet oxygen 소거와 관련이 있는 것으로 생각되며, 또한 cell free extract 는 T세포를 자극하여 생성된 액성인자에 의해 B세포에 항체 생성능을 증가시키는 것으로 나타났다.

• Asian-Australasian Journal of Animal Sciences
• /
• 제27권6호
• /
• pp.862-870
• /
• 2014

This study was conducted to investigate the effects of brown seaweed (Undaria pinnatifida) by-product and seaweed fusiforme (Hizikia fusiformis) by-product supplementation on growth performance and blood profiles including serum immunoglobulin (Ig) in broilers. Fermentation of seaweeds was conducted by Bacillus subtilis and Aspergillus oryzae. In a 5-wk feeding trial, 750 one-d-old broiler chicks were divided into 5 groups, and were assigned to the control diet or experimental diets including control+0.5% brown seaweed (BS) by-product, control+0.5% seaweed fusiforme (SF) by-product, control+0.5% fermented brown seaweed (FBS) by-product, and control+0.5% fermented seaweed fusiforme (FSF) by-product. As a consequence, body weight gain (BWG) and gain:feed of seaweed by-product groups were clearly higher, when compared to those of control diet group from d 18 to 35 and the entire experimental period (p<0.05). In mortality rate, seaweed by-product groups were significantly lower when compared to control diet group during entire experimental period (p<0.05). However, Feed Intake of experimental diets group was not different from that of the control group during the entire experimental period. Whereas, Feed Intake of fermented seaweed by-product groups was lower than that of non-fermented seaweed groups (p<0.05). Total organ weights, lipids, and glutamic oxalacetic transaminase (GOT) of all treatment groups were not different from those of control group. However, glutamic pyruvate transaminase (GPT) of all treatment groups was higher than that of control group at d 17 (p<0.05). In case of serum Igs concentration, the concentration of IgA antibody in BS, SF, FSF treatment groups was significantly higher than in control group at d 35 (p<0.01). IgA concentration in FBS supplementation groups was negligibly decreased when compared to the control group. IgM concentration in the serums of all treatment groups was significantly higher than in control group (p<0.05) and in fermented seaweed by-product groups were much higher than in non-fermented seaweed groups (p<0.05). On the other hand, IgG concentrations in all treatment groups were lower than in control group (p<0.05). Taken together, our results suggest that by-product dietary supplementation of BS, SF, FBS, and FSF in poultry may provide positive effects of growth performance and immune response.

• Journal of Microbiology and Biotechnology
• /
• 제11권1호
• /
• pp.143-152
• /
• 2001

Korean-style fermented soybean paste (KFSP), Doenjang, is a traditional food that is consumed as a protein source in Korea. Recently, efforts to identify biolgocial response modifiers (BRMs) have been focused on food products. Accordingly, this study which isolated abiologically active substance form KFSP, named KFSP-BRM, ws defined to be aheat-stable carbohydrate with a molecular weight of 2,000 kDa. The biological activity of KFSP-BRM was not inactivated by treatment with an anti-LPS antibody. The oral as well as intraperitoneal treatment of mice with KFSP-BRM significantly enhanced the number of B cells expressing surface significantly enhanced the number of B cells expressing surface immunoglobulins (IgM and IgG). Subsequently, an increased level of immunoglobulins in the sera was also observed. In vitro. KFSP-BRM was found to upregulate the production of interleukin-1 (IL-1) and IL-6 by mactro phages and B cells but not the production of IL-2 by T cells. In conclusion, these data demonstrate the presence of a BRM in KFSP, which may provide an additional benefit to those consuming it is a food. KFSP-BRM is a novel B cellmitogen distinct from fresh soybean lectin or B cell mitogens, such as LPS and Streptococcus protein A. The major biological effects of KFSP-BRM would appear to be anincreased production of IL-1 and IL-6 by macrophages and B cells, thereby enhancing the function of mature B cells.

• Journal of Microbiology and Biotechnology
• /
• 제32권10호
• /
• pp.1335-1343
• /
• 2022

COVID-19 is an emerging disease that poses a severe threat to global public health. As such, there is an urgent demand for vaccines against SARS-CoV-2, the virus that causes COVID-19. Here, we describe a virus-like nanoparticle candidate vaccine against SARS-CoV-2 produced by an E. coli expression system. The fusion protein of a truncated ORF2-encoded protein of aa 439~608 (p170) from hepatitis E virus CCJD-517 and the receptor-binding domain of the spike protein from SARS-CoV-2 were expressed, purified and characterized. The antigenicity and immunogenicity of p170-RBD were evaluated in vitro and in Kunming mice. Our investigation revealed that p170-RBD self-assembled into approximately 24 nm virus-like particles, which could bind to serum from vaccinated people (p < 0.001) and receptors on cells. Immunization with p170-RBD induced the titer of IgG antibody vaccine increased from 14 days post-immunization and was significantly enhanced after a booster immunization at 28 dpi, ultimately reaching a peak level on 42 dpi with a titer of 4.97 log₁₀. Pseudovirus neutralization tests showed that the candidate vaccine induced a strong neutralizing antibody response in mice. In this research, we demonstrated that p170-RBD possesses strong antigenicity and immunogenicity and could be a potential candidate for use in future SARS-CoV-2 vaccine development.